1. Home
  2. KWR vs LQDA Comparison

KWR vs LQDA Comparison

Compare KWR & LQDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KWR
  • LQDA
  • Stock Information
  • Founded
  • KWR 1918
  • LQDA 2004
  • Country
  • KWR United States
  • LQDA United States
  • Employees
  • KWR N/A
  • LQDA N/A
  • Industry
  • KWR Major Chemicals
  • LQDA Biotechnology: Pharmaceutical Preparations
  • Sector
  • KWR Industrials
  • LQDA Health Care
  • Exchange
  • KWR Nasdaq
  • LQDA Nasdaq
  • Market Cap
  • KWR 2.2B
  • LQDA 1.9B
  • IPO Year
  • KWR 1985
  • LQDA 2018
  • Fundamental
  • Price
  • KWR $135.62
  • LQDA $22.61
  • Analyst Decision
  • KWR Strong Buy
  • LQDA Strong Buy
  • Analyst Count
  • KWR 5
  • LQDA 9
  • Target Price
  • KWR $148.60
  • LQDA $32.67
  • AVG Volume (30 Days)
  • KWR 89.8K
  • LQDA 2.6M
  • Earning Date
  • KWR 10-30-2025
  • LQDA 11-12-2025
  • Dividend Yield
  • KWR 1.52%
  • LQDA N/A
  • EPS Growth
  • KWR N/A
  • LQDA N/A
  • EPS
  • KWR N/A
  • LQDA N/A
  • Revenue
  • KWR $1,832,674,000.00
  • LQDA $19,322,000.00
  • Revenue This Year
  • KWR $2.63
  • LQDA $405.58
  • Revenue Next Year
  • KWR $4.56
  • LQDA $373.93
  • P/E Ratio
  • KWR N/A
  • LQDA N/A
  • Revenue Growth
  • KWR N/A
  • LQDA 30.20
  • 52 Week Low
  • KWR $95.91
  • LQDA $9.71
  • 52 Week High
  • KWR $180.97
  • LQDA $29.94
  • Technical
  • Relative Strength Index (RSI)
  • KWR 54.32
  • LQDA 46.08
  • Support Level
  • KWR $129.24
  • LQDA $22.08
  • Resistance Level
  • KWR $134.24
  • LQDA $24.85
  • Average True Range (ATR)
  • KWR 3.61
  • LQDA 1.31
  • MACD
  • KWR 0.63
  • LQDA 0.02
  • Stochastic Oscillator
  • KWR 91.85
  • LQDA 23.52

About KWR Quaker Houghton

Quaker Houghton manufactures and sells a variety of industrial process fluids. The product portfolio of the company includes metal removal fluids, cleaning fluids, corrosion inhibitors, metal drawing and forming fluids, die-cast mold releases, heat treatment and quenchants, metal forging fluids, hydraulic fluids, specialty greases, offshore sub-sea energy control fluids, rolling lubricants, rod and wire drawing fluids and surface treatment chemicals. The geographic segments of the company include America, EMEA, Asia/Pacific, and Global Specialty Businesses. The majority of the revenue is earned from America.

About LQDA Liquidia Corporation

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also generates revenue from the sale of Treprostinil Injection through an agreement between its subsidiary and the manufacturer.

Share on Social Networks: